Author: Mariko Miyokawa
-
Regulatory and Safety Assessment of COVID-19 mRNA-LNP Genetic Vaccines in Japan: Evidence for Revocation of Approval and Market Withdrawal
Abstract This paper examines critical safety issues of mRNA lipid nanoparticle formulations (hereinafter referred to as genetic vaccines…
Editor’s Choice
About the Journal
This initiative exists to help insure that policies in public health practice and law are founded on a full consideration of available knowledge derived by robust science. From Dr Lyons-Weiler: “While IPAK will continue to conduct basic, clinical and translational biomedical research in a completely unbiased manner, and will pubish results regardless of the outcome, it will also be increasingly centered on questions of policy and law that impact public health, laws that impact public health, and cases and rulings that impact the citizen’s expression of self-governance through law. We’re putting the Public back into Public Health.”